当前位置: 首页 > 详情页

Biocompatibility of Magnetic Resonance Imaging Nanoprobes Improved by Transformable Gadolinium Oxide Nanocoils

文献详情

资源类型:

收录情况: ◇ SCIE ◇ EI ◇ 自然指数

机构: [1]State Key Laboratory of Heavy Oil Processing, Institute of New Energy, Beijing Key Laboratory of Biogas Upgrading Utilization, China University of Petroleum Beijing, Beijing 102249, China [2]Beijing National Laboratory for Molecular Sciences, Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, The Chinese Academy of Sciences, Beijing 100190, China [3]Department of Orthodontics, National Engineering Laboratory for Digital and Material Technology of Stomatology, Beijing Key Laboratory of Digital Stomatology, Peking University School and Hospital of Stomatology, Beijing 100081, China [4]Department of Radiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Disease, Beijing 100029, China
出处:
ISSN:

摘要:
To design functional nanomaterials for biomedical applications, the challenge for scientists is to gain further understanding of their unique toxicological properties. Nonspecific adhesion of proteins and endocytosis are considered to be the major biotoxic sources of imaging nanoprobes. Here, we fabricated ultrathin gadolinium oxide (Gd2O3) nanocoils with a low Young's modulus, which provides transformable properties in solution. The spatial configurational freedom of ultrathin nanocoils induces the steric repulsion to the nonspecific adsorption of proteins that, in turn, suppresses cellular uptake and thus improves their biocompatibility. The larger number of exposed surface gadolinium atoms of the ultrathin nanocoils provided enhanced T-1 magnetic resonance (MR) imaging contrast with high signal activation. Such nanocontrast agents were applied to in vivo MR bioimaging to achieve prolonged circulation lifetime. The improved biocompatibility by transformable Gd2O3 nanocoils could open up a new perspective toward the design and construction of various nano-biomedicines in the future.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 1 区 化学
小类 | 1 区 化学综合
最新[2023]版:
大类 | 1 区 化学
小类 | 1 区 化学:综合
JCR分区:
出版当年[2016]版:
Q1 CHEMISTRY, MULTIDISCIPLINARY
最新[2023]版:
Q1 CHEMISTRY, MULTIDISCIPLINARY

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]State Key Laboratory of Heavy Oil Processing, Institute of New Energy, Beijing Key Laboratory of Biogas Upgrading Utilization, China University of Petroleum Beijing, Beijing 102249, China
共同第一作者:
通讯作者:
通讯机构: [2]Beijing National Laboratory for Molecular Sciences, Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, The Chinese Academy of Sciences, Beijing 100190, China [3]Department of Orthodontics, National Engineering Laboratory for Digital and Material Technology of Stomatology, Beijing Key Laboratory of Digital Stomatology, Peking University School and Hospital of Stomatology, Beijing 100081, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院